Estradiol negative and positive feedback in a prenatal androgen-induced mouse model of polycystic ovarian syndrome

Endocrinology

Volumn 154, Issue 2, 2013, Pages 796-806

  Moore, Aleisha M ^a   Prescott, Melanie ^a   Campbell, Rebecca E ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTRADIOL; GONADORELIN; GREEN FLUORESCENT PROTEIN; LUTEINIZING HORMONE; PROTEIN C FOS; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; CONTROLLED STUDY; ESTRUS CYCLE; FEMALE; FERTILITY; HYPERANDROGENISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; MOUSE; NEGATIVE FEEDBACK; NERVE CELL; NONHUMAN; OVARIECTOMY; OVARY POLYCYSTIC DISEASE; POSITIVE FEEDBACK; PRENATAL CARE; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL;

ANIMALS; ESTRADIOL; ESTROUS CYCLE; FEEDBACK; FEMALE; LUTEINIZING HORMONE; MICE; OVARY; POLYCYSTIC OVARY SYNDROME; PUBERTY; TESTOSTERONE;

EID: 84872713513     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1954     Document Type: Article

References (53)

1. Padmanabhan V. Polycystic ovary syndrome - "a riddle wrapped in a mystery inside an enigma." J Clin Endocrinol Metab. 2009;94:1883-1885.
2. Azziz R, Marin C, Hoq L, Badamgarav E, Song P. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab. 2005;90:4650-4658. (Pubitemid 41159355)
3. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41-47.
4. Taylor AE, McCourt B, Martin KA, et al. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1997;82:2248-2256. (Pubitemid 27287593)
5. Wildt L, Hausler A, Marshall G, et al. Frequency and amplitude of gonadotropin-releasing hormone stimulation and gonadotropin secretion in the rhesus monkey. Endocrinology. 1981;109:376-385. (Pubitemid 11040187)
6. Burt Solorzano CM, Beller JP, Abshire MY, Collins JS, McCartney CR, Marshall JC. Neuroendocrine dysfunction in polycystic ovary syndrome. Steroids. 2012;77:332-337.
7. Herbison AE. Physiology of the gonadotropin-releasing hormone neuronal network. In: Neill JD, ed. Knobil and Neil's Physiology of Reproduction. 3rd ed. New York: Raven Press; 2006:1415-1482.
8. Ropelato MG, Rudaz MC, Escobar ME, et al. Acute effects of testosterone infusion on the serum luteinizing hormone profile in eumenorrheic and polycystic ovary syndrome adolescents. J Clin Endocrinol Metab. 2009;94:3602-3610.
9. Pielecka J, Quaynor SD, Moenter SM. Androgens increase gonadotropin-releasing hormone neuron firing activity in females and interfere with progesterone negative feedback. Endocrinology. 2006;147:1474-1479. (Pubitemid 43244382)
10. Daniels TL, Berga SL. Resistance of gonadotropin releasing hormone drive to sex steroid-induced suppression in hyperandrogenic anovulation. J Clin Endocrinol Metab. 1997;82:4179-4183. (Pubitemid 27525536)
11. Pastor CL, Griffin-Korf ML, Aloi JA, Evans WS, Marshall JC. Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab. 1998;83:582-590. (Pubitemid 28496543)
12. Shi D, Vine DF. Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk. Fertil Steril. 2012;98:185-193.
13. Abbott DH, Zhou R, Bird IM, Dumesic DA, Conley AJ. Fetal programming of adrenal androgen excess: lessons from a nonhuman primate model of polycystic ovary syndrome. Endocr Dev. 2008;13:145-158.
14. Xita N, Tsatsoulis A. Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. J Clin Endocrinol Metab. 2006;91:1660-1666.
15. Abbott DH, Barnett DK, Bruns CM, Dumesic DA. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum Reprod Update. 2005;11:357-374. (Pubitemid 40895465)
16. Franks S, Gilling-Smith C, Gharani N, McCarthy M. Pathogenesis of polycystic ovary syndrome: evidence for a genetically determined disorder of ovarian androgen production. Hum Fertil (Camb). 2000;3:77-79.
17. Hague WM, Adams J, Rodda C, et al. The prevalence of polycystic ovaries in patients with congenital adrenal-hyperplasia and their close relatives. Clin Endocrinol (Oxf). 1990;33:501-510. (Pubitemid 20290689)
18. Barnes RB, Rosenfield RL, Ehrmann DA, Cara JF, Cuttler L, Levitsky LL, Rosenthal IM. Ovarian hyperandrogenism as a result of congenital adrenal virilizing disorders - evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab. 1994;79:1328-1333. (Pubitemid 24369843)
19. Eisner JR, BarnettMA,Dumesic DA, AbbottDH. Ovarian hyperandrogenism in adult female rhesus monkeys exposed to prenatal androgen excess. Fertil Steril. 2002;77:167-172. (Pubitemid 34093911)
20. West C, Foster DL, Evans NP, Robinson J, Padmanabhan V. Intrafollicular activin availability is altered in prenatally-androgenized lambs. Mol Cell Endocrinol. 2001;185:51-59. (Pubitemid 33103953)
21. Wu XY, Li ZL, Wu CY, et al. Endocrine traits of polycystic ovary syndrome in prenatally androgenized female Sprague-Dawley rats. Endocr J. 2010;57:201-209.
22. Sullivan SD, Moenter SM. Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder. Proc Natl Acad Sci USA. 2004;101:7129-7134. (Pubitemid 38596454)
23. Campbell RE. Defining the gonadotrophin-releasing hormone neuronal network: transgenic approaches to understanding neurocircuitry. J Neuroendocrinol. 2007;19:561-573. (Pubitemid 47180046)
24. Roland AV, Moenter SM. Prenatal androgenization of female mice programs an increase in firing activity of gonadotropin-releasing hormone (GnRH) neurons that is reversed by metformin treatment in adulthood. Endocrinology. 2011;152:618-628.
25. Spergel DJ, Kruth U, Hanley DF, Sprengel R, Seeburg PH. GABA- and glutamate-activated channels in green fluorescent protein-tagged gonadotropin-releasing hormone neurons in transgenic mice. J Neurosci. 1999;19:2037-2050. (Pubitemid 29133382)
26. Lee K, Porteous R, Campbell RE, Luscher B, Herbison AE. Knockdown of GABA(A) receptor signaling in GnRH neurons has minimal effects upon fertility. Endocrinology. 2010;151:4428-4436.
27. Chan H, Prescott M, Ong Z, Herde MK, Herbison AE, Campbell RE. Dendritic spine plasticity in gonadatropin-releasing hormone (GnRH) neurons activated at the time of the preovulatory surge. Endocrinology. 2011;152:4906-4914.
28. Roland AV, Nunemaker CS, Keller SR, Moenter SM. Prenatal androgen exposure programs metabolic dysfunction in female mice. J Endocrinol. 2010;207:213-223.
29. Witham EA, Meadows JD, Shojaei S, Kauffman AS, Mellon PL. Prenatal exposure to low levels of androgen accelerates female puberty onset and reproductive senescence in mice. Endocrinology. 2012;153:4522-4532.
30. Zuloaga DG, Puts DA, Jordan CL, Breedlove SM. The role of androgen receptors in the masculinization of brain and behavior: what we've learned from the testicular feminization mutation. Horm Behav. 2008;53:613-626.
31. Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update. 2003;9:505-514. (Pubitemid 38072143)
32. Chang RJ, Cook-Andersen H. Disordered follicle development [published online ahead of print July 31, 2012]. Mol Cell Endocrinol. doi:10.1016/j.mce. 2012.07.011
33. McNatty KP, Makris A, DeGrazia C, Osathanondh R, Ryan KJ. The production of progesterone, androgens, and estrogens by granulosa cells, thecal tissue, and stromal tissue from human ovaries in vitro. J Clin Endocrinol Metab. 1979;49:687-699.
34. Smith P, Steckler TL, Veiga-Lopez A, Padmanabhan V. Developmental programming: differential effects of prenatal testosterone and dihydrotestosterone on follicular recruitment, depletion of follicular reserve, and ovarian morphology in sheep. Biol Reprod. 2009;80:726-736.
35. Manneras L, Cajander S, Holmang A, et al. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology. 2007;148:3781-3791. (Pubitemid 47105840)
36. van Houten EL, Kramer P, McLuskey A, Karels B, Themmen AP, Visser JA. Reproductive and metabolic phenotype of a mouse model of PCOS. Endocrinology. 2012;153:2861-2869.
37. Azziz R, Carmina E, Dewailly D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91:456-488.
38. Barry JA, Kay AR, Navaratnarajah R, et al. Umbilical vein testosterone in female infants born to mothers with polycystic ovary syndrome is elevated to male levels. J Obstet Gynaecol. 2010;30:444-446.
39. Maliqueo M, Sir-Petermann T, Perez V, et al. Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2009;94:3282-3288.
40. Sir-Petermann T, Codner E, Perez V, et al. Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2009;94:1923-1930.
41. Chhabra S, McCartney CR, Yoo RY, Eagleson CA, Chang RJ, Marshall JC. Progesterone inhibition of the hypothalamic gonadotropin-releasing hormone pulse generator: evidence for varied effects in hyperandrogenemic adolescent girls. J Clin Endocrinol Metab. 2005;90:2810-2815. (Pubitemid 40686328)
42. McCartney CR, Eagleson CA, Marshall JC. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome. Semin Reprod Med. 2002;20:317-326.
43. Foecking EM, Szabo M, Schwartz NB, Levine JE. Neuroendocrine consequences of prenatal androgen exposure in the female rat: absence of luteinizing hormone surges, suppression of progesterone receptor gene expression, and acceleration of the gonadotropin-releasing hormone pulse generator. Biol Reprod. 2005;72:1475-1483. (Pubitemid 40696090)
44. Herbison AE. Multimodal influence of estrogen upon gonadotropin-releasing hormone neurons. Endocr Rev. 1998;19:302-330. (Pubitemid 29117818)
45. Chu Z, Andrade J, Shupnik MA, Moenter SM. Differential regulation of gonadotropin-releasing hormone neuron activity and membrane properties by acutely applied estradiol: dependence on dose and estrogen receptor subtype. J Neurosci. 2009;29:5616-5627.
46. Kwakowsky A, Herbison AE, Abraham IM. The role of cAMP response element-binding protein in estrogen negative feedback control of gonadotropin-releasing hormone neurons. J Neurosci. 2012;32:11309-11317.
47. Sullivan SD, Moenter SM. GABAergic integration of progesterone and androgen feedback to gonadotropin-releasing hormone neurons. Biol Reprod. 2005;72:33-41. (Pubitemid 40013751)
48. Wang HJ, Hoffman GE, Smith MS. Increased GnRH mRNA in the GnRH neurons expressing cFos during the proestrous LH surge. Endocrinology. 1995;136:3673-3676.
49. Rajendren G. Subsets of gonadotropin-releasing hormone (GnRH) neurons are activated during a steroid-induced luteinizing hormone surge and mating in mice: a combined retrograde tracing double immunohistochemical study. Brain Res. 2001;918:74-79. (Pubitemid 33001491)
50. Herbison AE, Moenter SM. Depolarising and hyperpolarising actions of GABA(A) receptor activation on gonadotrophin-releasing hormone neurones: towards an emerging consensus. J Neuroendocrinol. 2011;23:557-569.
51. McKinney RA. Excitatory amino acid involvement in dendritic spine formation, maintenance and remodelling. J Physiol. 2010;588:107-116.
52. Cottrell EC, Campbell RE, Han SK, Herbison AE. Postnatal remodeling of dendritic structure and spine density in gonadotropin-releasing hormone neurons. Endocrinology. 2006;147:3652-3661. (Pubitemid 44079369)
53. Campbell RE, Han SK, Herbison AE. Biocytin filling of adult gonadotropin-releasing hormone neurons in situ reveals extensive, spiny, dendritic processes. Endocrinology. 2005;146:1163-1169. (Pubitemid 40289305)